Cell Signalling and Pharmacology Research Group, Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, UK.
Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham and University of Nottingham, Midlands, UK.
FASEB J. 2021 Apr;35(4):e21211. doi: 10.1096/fj.202001729RR.
Organization of G protein-coupled receptors at the plasma membrane has been the focus of much recent attention. Advanced microscopy techniques have shown that these receptors can be localized to discrete microdomains and reorganization upon ligand activation is crucial in orchestrating their signaling. Here, we have compared the membrane organization and downstream signaling of a mutant (R108A, R3.50A) of the adenosine A receptor (A AR) to that of the wild-type receptor. Fluorescence Correlation Spectroscopy (FCS) studies with a fluorescent agonist (ABEA-X-BY630) demonstrated that both wild-type and mutant receptors bind agonist with high affinity but in subsequent downstream signaling assays the R108A mutation abolished agonist-mediated inhibition of cAMP production and ERK phosphorylation. In further FCS studies, both A AR and A AR R108A underwent similar agonist-induced increases in receptor density and molecular brightness which were accompanied by a decrease in membrane diffusion after agonist treatment. Using bimolecular fluorescence complementation, experiments showed that the R108A mutant retained the ability to recruit β-arrestin and these receptor/arrestin complexes displayed similar membrane diffusion and organization to that observed with wild-type receptors. These data demonstrate that effective G protein signaling is not a prerequisite for agonist-stimulated β-arrestin recruitment and membrane reorganization of the A AR.
G 蛋白偶联受体在质膜中的组织一直是近期研究的重点。先进的显微镜技术表明,这些受体可以定位于离散的微区,并且配体激活后的重排对于协调它们的信号转导至关重要。在这里,我们比较了腺苷 A 受体 (A AR) 的突变体 (R108A、R3.50A) 和野生型受体的膜组织和下游信号转导。用荧光激动剂 (ABEA-X-BY630) 进行荧光相关光谱 (FCS) 研究表明,野生型和突变型受体都以高亲和力结合激动剂,但在随后的下游信号转导测定中,R108A 突变消除了激动剂介导的 cAMP 产生和 ERK 磷酸化的抑制。在进一步的 FCS 研究中,A AR 和 A AR R108A 都经历了类似的激动剂诱导的受体密度和分子亮度增加,随后在激动剂处理后膜扩散减少。使用双分子荧光互补实验表明,R108A 突变体保留了募集β-arrestin 的能力,这些受体/β-arrestin 复合物显示出与观察到的野生型受体相似的膜扩散和组织。这些数据表明,有效的 G 蛋白信号转导不是激动剂刺激β-arrestin 募集和 A AR 膜重排的必要条件。